FuelCell Energy Reports Q2 Loss, $156M Capital Raise, and 500MW Manufacturing Expansion
Summary
FuelCell Energy announced weak Q2 fiscal 2026 financial results, including increased losses and a $42.6 million impairment, but bolstered its cash position by raising $156.6 million through ATM sales to fund a significant manufacturing expansion and capitalize on a growing data center pipeline.
Key Events
-
Weak Q2 Financial Performance
Reported a 5% decrease in revenue to $35.6 million, a 37% increase in gross loss to $(12.9) million, and a 118% increase in loss from operations to $(77.9) million year-over-year. Net loss per share was $(1.45).
-
Significant Impairment Charge
Incurred a non-cash impairment expense of $42.6 million related to upgrading equipment at the Groton Project.
-
Substantial Capital Raise
Raised approximately $100.4 million net from ATM sales during Q2 and an additional $52.9 million net subsequent to quarter-end, totaling $153.3 million net proceeds. This significantly increased cash and cash equivalents to $440.9 million.
-
Manufacturing Capacity Expansion
Initiated expansion of its Torrington, CT manufacturing facility to support an annualized production rate of up to 500 MW, with an estimated cost of $200-$275 million over the next 24 months.
Analysis
FuelCell Energy reported a significant increase in operating losses and a substantial impairment charge for Q2 fiscal 2026, indicating ongoing financial challenges. However, the company successfully raised approximately $156.6 million through its At-The-Market (ATM) program, providing critical liquidity. This capital infusion, while dilutive, supports the company's strategic initiatives, including a major expansion of its manufacturing capacity to 500 MW and a growing sales pipeline, particularly in the data center market. The market will weigh the poor financial performance against the strengthened balance sheet and strategic progress.
At the time of this filing, FCEL was trading at $15.61 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $918.1M. The 52-week trading range was $3.78 to $27.69. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.